291306-20-2

Upstream product

• 79617-96-2 Sertraline 
• 79559-97-0 sertraline hydrochloride 

Downstream Products

• 960287-40-5 (1S-cis)-4-(3,4-dichlorophenyl)-7-iodo-1,2,3,4-tetrahydro-N-tert-butoxycarbonyl-N-methyl-1-naphthalenamine 
• 291305-37-8 cis-(1S)-N-methyl-7-(5-(3-methyl-1,2,4-oxadiazolyl))-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine 
• 291306-22-4 Cis-(1S)-N-methyl-7-(methoxycarbonyl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine 
• 291306-23-5 cis-(1S)-N-methyl-7-(N-(methoxycarbonylmethyl)amino)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine 
• 291306-28-0 cis-(1S)-N-methyl-7-(boronato)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine 
• 291306-21-3 Cis-(1S)-N-methyl-7-cyano-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine hydrochloride 
• 291306-34-8 cis-(1S)-N-methyl-7-(2-(methylsulphonyl)vinyl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine 
• 291305-53-8 cis-(1S)-N-methyl-7-(3-(N⁽²⁾-methyl)pyrazolyl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine 
• 291306-30-4 cis-(1S)-N-methyl-7-(4-(N⁽¹⁾-ethoxymethyl)pyrazolyl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine 
• 291306-31-5 cis-(1S)-N-methyl-7-(5-(N⁽¹⁾-ethoxymethyl)pyrazolyl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine 
• 761389-54-2 cis-(1S)-N-methyl-7-(3-(N⁽²⁾methyl-1,2,4-triazolyl))-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine hydrochloride 
• 291305-56-1 cis-(1S)-N-methyl-7-(5-(N⁽¹⁾methyl-1,2,3-triazolyl))-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine 
• 291306-33-7 cis-(1S)-N-methyl-7-(4-(3-(ethoxymethyl)-1,2,3-triazolyl))-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine 
• 291306-32-6 cis-(1S)-N-methyl-7-(3-((2-ethoxymethyl)-1,2,4-triazolyl))-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine 

Relevant academic research and scientific papers

PSYCHOTROPIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE

The present invention provides a method for treating or preventing a disease or disorder treatable by the inhibition of serotonin reuptake in a patient, and/or norepinephrine reuptake and/or dopamine reuptake in a patient, the method comprising administer

ANTIPROLIFERATIVE COMPOUNDS, COMPOSITIONS AND METHODS OF USE

The present invention provides a compound of the formula A-L-B (I) or a pharmaceutically acceptable salt, ester or prodrug thereof, wherein A is a psychotropic derivative; L is a linking group comprising two carbon atoms; and B is an alkyl, alkenyl, alkyn